azomycin has been researched along with indocyanine green in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aguirre, A; Biswal, NC; Claffey, KP; Kuhn, LT; Pavlik, C; Smith, MB; Xu, Y; Zanganeh, S; Zhu, Q | 1 |
| Aguirre, A; Kuhn, L; Mohammad, I; Smith, MB; Wang, T; Xu, Y; Yang, Y; Zanganeh, S; Zhu, Q | 1 |
| Abuteen, A; Dietz, C; Mohammad, I; Smith, MB; Zanganeh, S; Zhou, F; Zhu, Q | 1 |
| Dietz, C; Erfanzadeh, M; Smith, MB; Wang, L; Yao, X; Zhou, F; Zhu, Q | 1 |
4 other study(ies) available for azomycin and indocyanine green
| Article | Year |
|---|---|
Imaging tumor hypoxia by near-infrared fluorescence tomography.
Topics: Animals; Cell Hypoxia; Female; Immunohistochemistry; Indocyanine Green; Mice; Mice, Inbred BALB C; Molecular Imaging; Neoplasm Transplantation; Neoplasms; Nitroimidazoles; Spectrometry, Fluorescence; Spectroscopy, Near-Infrared; Tomography | 2011 |
Targeting tumor hypoxia with 2-nitroimidazole-indocyanine green dye conjugates.
Topics: Animals; Cell Line, Tumor; Coloring Agents; Equipment Design; Ethanolamine; Female; Hypoxia; Immunohistochemistry; Indocyanine Green; Magnetic Resonance Spectroscopy; Mice; Mice, Inbred BALB C; Neoplasm Transplantation; Neoplasms; Nitroimidazoles; Spectrometry, Fluorescence; Time Factors | 2013 |
Targeting tumor hypoxia: a third generation 2-nitroimidazole-indocyanine dye-conjugate with improved fluorescent yield.
Topics: Animals; Cell Hypoxia; Cell Line, Tumor; Fluorescent Dyes; Hypoxia; Indocyanine Green; Mice, Inbred BALB C; Neoplasms; Nitroimidazoles; Optical Imaging | 2015 |
Treasure hunt for peptides with undefined chemical modifications: Proteomics identification of differential albumin adducts of 2-nitroimidazole-indocyanine green in hypoxic tumor.
Topics: Albumins; Animals; Indocyanine Green; Mice; Neoplasms, Experimental; Nitroimidazoles; Optical Imaging; Peptides; Proteome; Proteomics; Tumor Hypoxia | 2020 |